List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 186 studies with search of: "Lopinavir"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs;   Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs;   Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs;   Drug: lopinavir/ritonavir cap (tablet or capsule) with NRTIs
2 Completed A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir;   Drug: lopinavir/ritonavir
3 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Lopinavir/ritonavir;   Drug: Lopinavir/ritonavir
4 Recruiting Lopinavir/Ritonavir (Kaletra)PK
Conditions: HIV/AIDS Treatment;   HIV Infections
Interventions: Drug: lopinavir/ritonavir (Kaletra®) tablets;   Drug: lopinavir/ritonavir (Kaletra®) tablets
5 Completed Dose Reduction of Lopinavir in Children
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir standard dose According to WHO simplified dosing table;   Drug: Lopinavir/ritonavir low dose ( 70% of WHO recommended dosing table)
6 Not yet recruiting Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.
Condition: Thrombocytopenia
Interventions: Drug: Eltrombopag and Lopinavir/Ritonavir;   Drug: Lopinavir/Ritonavir;   Drug: Eltrombopag
7 Terminated Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Conditions: HIV Infections;   Kaletra
Interventions: Drug: lopinavir/ritonavir;   Drug: lopinavir /ritonavir
8 Active, not recruiting Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
9 Completed Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir;   Drug: lamivudine/zidovudine
10 Terminated A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin
11 Recruiting Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lopinavir / ritonavir;   Drug: Lopinavir/ritonavir
12 Recruiting Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
Conditions: HIV Infection;   Lipodystrophy;   HIV Infections
Interventions: Drug: Monotherapy (Lopinavir/ritonavir);   Drug: Monotherapy (Lopinavir/ritonavir) + ABC/3TC
13 Recruiting Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
Condition: HIV Infections
Interventions: Drug: Lumefantrine - lopinavir/ritonavir drug interaction;   Drug: Lumefantrine only arm
14 Terminated Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV co-Infected Subjects vs Baseline Liver Biopsy Metavir Score
Condition: HIV Infection
Intervention: Drug: Lopinavir/Ritonavir
15 Completed Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: Tenofovir DF;   Drug: lopinavir/ritonavir with 2 Nucleoside RTIs
16 Recruiting Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
Conditions: HIV/HCV co-Infection;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Lopinavir/ritonavir with two nucleoside analogs
17 Recruiting GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir
Condition: Healthy Volunteer
Interventions: Drug: Darunavir;   Drug: Etravirine;   Drug: Ritonavir;   Drug: Lopinavir/ritonavir;   Drug: GSK1349572
18 Recruiting ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
Condition: HIV-1
Interventions: Drug: Truvada (emtricitabine 200 mg/tenofovir DF 300 mg) and Kaletra (lopinavir 200 mg/ritonavir;   Drug: Kivexa (abacavir (as sulfate) 600 mg/lamivudine and Kaletra (lopinavir 200 mg/ritonavir
19 Recruiting TDM of Generic Lopinavir/Ritonavir 200/50 mg
Condition: HIV
Intervention: Drug: generic lopinavir/ritonavir
20 Completed ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Lamivudine;   Drug: Stavudine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services